Warner Financial’s iShares Biotechnology ETF IBB Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$452K Hold
2,379
0.13% 97
2026
Q1
$402K Hold
2,379
0.14% 93
2025
Q4
$401K Hold
2,379
0.14% 92
2025
Q3
$343K Hold
2,379
0.13% 99
2025
Q2
$301K Sell
2,379
-55
-2% -$6.75K 0.12% 96
2025
Q1
$311K Sell
2,434
-57
-2% -$7.73K 0.14% 92
2024
Q4
$329K Buy
2,491
+1
+0% +$141 0.14% 92
2024
Q3
$362K Buy
2,490
+4
+0.2% +$579 0.16% 91
2024
Q2
$341K Hold
2,486
0.17% 91
2024
Q1
$341K Buy
2,486
+2
+0.1% +$273 0.17% 90
2023
Q4
$337K Buy
+2,484
New +$303K 0.19% 80

Other funds holding IBB

Warner Financial's IBB Position: Q2 2026 in Review

Warner Financial held its iShares Biotechnology ETF (IBB) position steady in Q2 2026 at 2,379 shares worth $452K. The position accounts for 0.13% of the portfolio, ranked #97.

Warner Financial first reported a position in IBB in Q4 2023 and has held it in 11 quarters since. 421 funds tracked by Wall St. Rank hold IBB as of Q2 2026.

  • Warner Financial held 2,379 shares of iShares Biotechnology ETF worth $452K as of Q2 2026.
  • Warner Financial left its iShares Biotechnology ETF share count unchanged in Q2 2026.
  • iShares Biotechnology ETF made up 0.13% of Warner Financial's portfolio in Q2 2026, its #97 holding.
  • Warner Financial first reported a position in iShares Biotechnology ETF in Q4 2023 and has held it in 11 quarters since.
  • 421 funds tracked by Wall St. Rank held iShares Biotechnology ETF as of Q2 2026.

Based on Warner Financial's 13F filing for Q2 2026, filed 9 Jul 2026.